{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T03:08:39Z","timestamp":1774494519741,"version":"3.50.1"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Dysregulation of immune system could be a vital stimulant of colorectal cancer development. We aimed to provide the most comprehensive meta-analysis on this topic.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Observational cohort studies reporting incidence or risk ratio of colorectal cancer among patients with autoimmune disorders as exposures were eligible. Relative risk was the primary endpoint and adjusted risk ratio were effect sizes. Incident cases per 100 000 person-years at risk were used for incidence analysis as secondary endpoint.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      523 studies were included, containing 91 265 886 participants. Overall pooled risk ratio was 1.244 (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.001). The results were consistent irrespective of sub-localization (colon: 1.308,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.001; rectum: 1.173,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.001), sex (male: 1.229,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.001; female: 1.209,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.001) and country (Nordic: 1.301,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.001; Western: 1.213,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.001; East Asian: 1.213,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.001). Specifically, primary sclerosing cholangitis, idiopathic inflammatory myopathies, inflammatory bowel disease, autoimmune hepatitis, ANCA-associated vasculitis, sarcoidosis, scleroderma, type 1 diabetes, psoriasis, membranous nephropathy, hidradenitis suppurativa and idiopathic thrombocytopenic purpura were associated with higherrisk of colorectal cancer. Interestingly, several autoimmune diseases might help to lower colorectal cancer risk, especially rheumatoidarthritis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Patients with autoimmune diseases were associated with higher risk of colorectal cancer under generally or specific settings. Unlike ourgastric and small bowel cancer pooled results, this risk-increasing impact on colorectal cancer was consistent across Nordic, Western and East Asian countries. Both digestive organ-specific or systemic autoimmune diseases could significantly increase risk of colorectal cancer. However, several autoimmune diseases might act as protective factors against colorectal cancer, especially rheumatoid arthritis, while not on gastric or small bowel carcinogenesis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/js9.0000000000002837","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T14:00:12Z","timestamp":1750428012000},"page":"7236-7242","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Incidence and relative risk of colorectal cancer in autoimmune diseases: a global pooled-analysis with more than 91 million participants"],"prefix":"10.1097","volume":"111","author":[{"given":"Ji","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guobin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,6,20]]},"reference":[{"key":"R1-20260109","doi-asserted-by":"crossref","first-page":"294\u2013310","DOI":"10.1016\/S0140-6736(24)00360-X","article-title":"Colorectal cancer","volume":"404","author":"Eng","year":"2024","journal-title":"Lancet"},{"key":"R2-20260109","first-page":"229\u201363","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R3-20260109","doi-asserted-by":"crossref","first-page":"102882","DOI":"10.1016\/j.autrev.2021.102882","article-title":"Autoimmunity and cancer","volume":"20","author":"Masetti","year":"2021","journal-title":"Autoimmun Rev"},{"key":"R4-20260109","doi-asserted-by":"crossref","first-page":"591\u2013602","DOI":"10.1038\/s41571-021-00508-x","article-title":"Beneficial autoimmunity improves cancer prognosis","volume":"18","author":"Zitvogel","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"R5-20260109","doi-asserted-by":"crossref","first-page":"662\u201380","DOI":"10.1038\/s41568-020-0285-7","article-title":"The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy","volume":"20","author":"Bruni","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"R6-20260109","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.cell.2020.07.005","article-title":"Coordinated cellular neighborhoods orchestrate antitumoral immunity at the colorectal cancer invasive front","volume":"182","author":"Schurch","year":"2020","journal-title":"Cell"},{"key":"R7-20260109","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.ccell.2023.04.011","article-title":"Remodeling of the immune and stromal cell compartment by PD-1 blockade in mismatch repair-deficient colorectal cancer","volume":"41","author":"Li","year":"2023","journal-title":"Cancer Cell"},{"key":"R8-20260109","doi-asserted-by":"crossref","first-page":"e209885","DOI":"10.1212\/WNL.0000000000209885","article-title":"Cancer risk among patients with multiple sclerosis: a 10-year nationwide retrospective cohort study","volume":"103","author":"Pierret","year":"2024","journal-title":"Neurology"},{"key":"R9-20260109","first-page":"1030\u201338","article-title":"Thiopurines and the risk of cancer in patients with inflammatory bowel disease and reference individuals without inflammatory bowel disease \u2013 a Danish nationwide cohort study (1996-2018)","volume":"23","author":"Wewer","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R10-20260109","doi-asserted-by":"crossref","first-page":"1129\u201331","DOI":"10.1016\/j.jaad.2022.08.017","article-title":"Investigating the risk of malignancy in elderly patients with psoriasis: a population-based retrospective matched cohort study","volume":"88","author":"Finstad","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"R11-20260109","doi-asserted-by":"crossref","first-page":"384\u201395","DOI":"10.1093\/ibd\/izac096","article-title":"Inflammatory bowel disease and long-term risk of cancer: a prospective cohort study among half a million adults in UK biobank","volume":"29","author":"Wu","year":"2023","journal-title":"Inflamm Bowel Dis"},{"key":"R12-20260109","doi-asserted-by":"crossref","first-page":"105906","DOI":"10.1016\/j.ijsu.2021.105906","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"88","author":"Page","year":"2021","journal-title":"Int J Surg"},{"key":"R13-20260109","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13643-016-0258-9","article-title":"Quality of conduct and reporting in rapid reviews: an exploration of compliance with PRISMA and AMSTAR guidelines","volume":"5","author":"Kelly","year":"2016","journal-title":"Syst Rev"},{"key":"R14-20260109","doi-asserted-by":"crossref","first-page":"j4008","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"BMJ"},{"key":"R15-20260109","first-page":"100082","article-title":"Transparency In The reporting of Artificial INtelligence \u2013 the TITAN guideline","volume":"10","author":"Agha","year":"2025","journal-title":"Prem J Sci"},{"key":"R16-20260109","doi-asserted-by":"crossref","first-page":"421\u201329","DOI":"10.1001\/jamadermatol.2020.0024","article-title":"Incidence, and risk of cancer in patients with psoriasis and psoriatic arthritis: a systematic review and meta-analysis","volume":"156","author":"Vaengebjerg","year":"2020","journal-title":"JAMA Dermatol"},{"key":"R17-20260109","doi-asserted-by":"crossref","first-page":"2273\u201382","DOI":"10.1097\/JS9.0000000000002219","article-title":"Autoimmune diseases and risk of gastrointestinal cancer: an umbrella review of meta-analyses of observational studies","volume":"111","author":"Bai","year":"2025","journal-title":"Int J Surg"},{"key":"R18-20260109","doi-asserted-by":"crossref","first-page":"209\u201319","DOI":"10.1001\/jamaoncol.2021.5680","article-title":"Immune-mediated diseases associated with cancer risks","volume":"8","author":"He","year":"2022","journal-title":"JAMA Oncol"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000002837","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T13:01:08Z","timestamp":1767963668000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000002837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,20]]},"references-count":18,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000002837","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,20]]},"assertion":[{"value":"2025-05-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-08","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}